Profile for Poland Patent: 2968290
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Poland Patent: 2968290
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Mar 14, 2034 | Pharmacosmos | COSELA | trilaciclib dihydrochloride |
| ⤷ Start Trial | Mar 14, 2034 | Pharmacosmos | COSELA | trilaciclib dihydrochloride |
| ⤷ Start Trial | Oct 25, 2031 | Pharmacosmos | COSELA | trilaciclib dihydrochloride |
| ⤷ Start Trial | Mar 14, 2034 | Pharmacosmos | COSELA | trilaciclib dihydrochloride |
| ⤷ Start Trial | Mar 14, 2034 | Pharmacosmos | COSELA | trilaciclib dihydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
